Breast Cancer Clinical Trials in Columbia, SC

Breast Cancer Clinical Trials in Columbia, SC

View the best 10 breast cancer medical studies in Columbia, South Carolina. Access promising new therapies by applying to a Columbia-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in Columbia, South Carolina

Here are the top 10 medical studies for breast cancer in Columbia, South Carolina

Image of University of South Carolina in Columbia, United States.

Physical activity adoption

Behavioral Intervention

Recruiting1 award6 criteria
This trialwill measure effects of a 3-month physical activity intervention on breast cancer survivors not currently active. A web-based platform and virtual calls with a peer coach will be used to increase activity. Participants will be given a Fitbit to monitor activity.
Image of Research Site in Mobile, United States.

AZD9833 +2 More

Selective Estrogen Receptor Degrader (SERD)

Recruiting1 awardPhase 3
This trial is testing whether a new drug combo is better than a current standard of care for treating a certain type of breast cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Fludeoxyglucose F-18

Recruiting1 awardPhase 2
This trial looks at how well FDG-PET/CT works in assessing the response of patients with bone-dominant metastatic breast cancer to treatment.
Image of Oncology Consultants in Houston, United States.

Eftilagimod Alpha +1 More

Immunomodulator

Recruiting0 awardsPhase 2 & 3
This trial will compare a chemo-immunotherapy to chemotherapy alone to see if it can better treat metastatic breast cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Trastuzumab Emtansine

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial tests a combination of two drugs to see if they're better than one drug at preventing breast cancer from coming back in patients with high risk, HER2 positive breast cancer.
Image of University of Colorado in Aurora, United States.

CAB-ROR2-ADC

Antibody-drug conjugate

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug to see if it is safe and effective.
Image of Research Site in Columbus, United States.

Arm B: camizestrant ± abemaciclib

Recruiting2 awardsPhase 3
This trial studies if a new drug can help improve outcomes for breast cancer patients with a high risk of recurrence. Treatment lasts 7 years.
Image of Research Site in Duarte, United States.

Dato-DXd +3 More

Antibody-drug conjugate

Recruiting2 awardsPhase 3
This trial is testing a new cancer treatment against the current best treatment for a particular type of aggressive breast cancer, to see if the new treatment is more effective and has fewer side effects.
Image of University of Alabama at Birmingham in Birmingham, United States.

Abemaciclib

CDK4/6 Inhibitor

Recruiting1 awardPhase 3
This trial is testing abemaciclib as a treatment for early breast cancer in people who are also taking hormone therapy. It will last up to 10 years.
Image of Banner Health/Banner Research in Phoenix, United States.

Quality-of-Life Assessment

Recruiting1 award3 criteria
This trial is testing whether eliminating surgery and just using radiation therapy after systemic therapy works well in treating patients with HER2 positive or triple negative breast cancer.

Popular filter options for breast-cancer columbia trials

Phase 3 Clinical Trials

View 91 phase 3 medical studies.

Clinical Trials With No Placebo

View 91 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.